They’re both high debt companies. TEVA is bigger. Former subscribers are in TEVA. I think its fine for them to still own it, but it wouldn’t be a new recommendation.
And,…we wouldn’t buy a stock just because one thing may get approved. We only buy companies because they are first fundamentally solid and fundamentally cheap. THEN, if they happen to additionally have something that can be a new catalyst additionally, that’s fine. That’s where we were in GILD when we were in it.
FDA looking to approve hydroxychloroquine (combined with others) as treatment for CV. Do you think MYL and TEVA are strong enough fundamentally for our interest?
I have two stock accounts that I trade in, one is an IRA and the other is a regular account. I’m retired and I have a monthly transfer from my IRA to my regular account and keep the transfer amount such that I do not incur an income tax liability at the end of the year. This has been working well. However, I’m getting to the point in my IRA account, I may have to sell some stock to make the transfer. The good news is that with the zero trading fees these days, I could just repurchase the stock in my regular account.
However, and this is the crux of my question; some of the stocks I have in the IRA account are some of the old UWR and AP. I also have stocks in the IRA account that have been LI recommendations. So here’s the question, when I need to sell some of my stocks in my IRA to transfer to the regular stock account, do I sell more recent stocks from the more current LI recommendations and then repurchase them in the regular account, OR; do I sell the old stocks that I’m really upside down on IE: TUR, RIG, MBT, TEVA? If I sell the older ones, I know that is taking a loss, but would I be better off in the long run taking the proceeds and putting the funds to work in the LI recommendation or requrchase the old UWR and AP stocks?
Because TEVA is a high-debt company, I’d encourage you to exit it as soon as profitable. So since you’re profitable, I’d rather see you have the money in something sounder. Congrats on your gains!
Just out of habit, I’d encourage you to talk about all stocks by name in the Member’s Forum area, even though the only ones that have to be discussed there are the LI positions.
Teva has too high of a debt load for further averaging down. Yet, I’d be fine in holding what you have in it. Warren Buffett still owns it and it looks like most of the opioid stuff is behind them.
TEVA is not one of our current recommendations. You may not want to average down into something that is not a current recommendation. Save the cash for future opportunities.
Author
Search Results
Viewing 8 results - 106 through 120 (of 121 total)
